By Caroline Scott-Thomas
After two days of hearings, a Food and Drug Administration (FDA) advisory panel has called for more research to decide whether genetically engineered salmon is safe for consumption.
The meetings pitted consumer and environmental campaigners against AquaBounty, the Massachusetts-based company that has been working on bringing its AquAvantage salmon to the market for more than a decade. If approved, the salmon, which is said to reach full size in about half the time as its conventional counterparts, would be the first genetically modified (GM) animal marketed for human consumption. Some environmentalists and scientists have said they see it as a watershed case, with the result likely to either pave the way for further genetic engineering of food animals or discourage its use.
Read full post at Food Navigator